Quantum BioPharma Balance Sheet Health

Financial Health criteria checks 5/6

Quantum BioPharma has a total shareholder equity of $10.2M and total debt of $615.6K, which brings its debt-to-equity ratio to 6%. Its total assets and total liabilities are $15.2M and $5.0M respectively.

Key information

6.0%

Debt to equity ratio

US$615.56k

Debt

Interest coverage ration/a
CashUS$3.33m
EquityUS$10.20m
Total liabilitiesUS$5.04m
Total assetsUS$15.25m

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 0K91's short term assets ($10.0M) exceed its short term liabilities ($5.0M).

Long Term Liabilities: 0K91 has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: 0K91 has more cash than its total debt.

Reducing Debt: 0K91's debt to equity ratio has increased from 2.9% to 6% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 0K91 has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: 0K91 is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies